Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 31, 1673-1681, November 1, 1971]
© 1971 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanders, B. G.
Right arrow Articles by Wiley, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanders, B. G.
Right arrow Articles by Wiley, K. L.

Serum and Urinary Protein Alterations in C57BL/10 Lymphoma-bearing Mice1

Bob G. Sanders2, Ray L. Teplitz3 and Kay L. Wiley

Department of Zoology, The University of Texas at Austin, Austin, Texas 78712 [B. G. S., K. L. W.], and Department of Cytogenetics and Cytology, City of Hope Medical Center, Duarte, California 91010 [R. L. T.]

Spleen extracts and sera from C57BL/10 mice bearing a reticulum cell lymphoma were found to contain elevated levels of protein when compared with normal mouse levels. Immunodiffusion, immunoelectrophoresis, gel filtration, and density gradient ultracentrifugation studies indicated the protein to be an IgM macroglobulin. The increased macroglobulin level was correlated, in part, with the growth of the tumor, reaching a peak 2.5 times greater than that for the control mice. The peak was reached 6 days after tumor transplant and remained at this level until the animals died from the tumor, approximately 14 days after the transplant.

Purified IgM from lymphomatous and normal mice were indistinguishable immunologically as antigens. Peptide map analyses of isolated light chains from partially reduced and alkylated IgM suggested that the IgM light chains from tumor-bearing mice were more heterogeneous than myeloma light chains; i.e., the elevated IgM was not a myeloma.

A protein was found in the urine of tumorous mice that migrated electrophoretically in the globulin region. Immunological studies and peptide map analyses revealed the protein to be albumin-like. The significance or relationship of the electrophoretically altered albumin to the elevated IgM levels or to the growth of the lymphoma was not determined.

1 This research was supported by research funds obtained from the University of Texas at Austin, Austin, Texas 78712.

2 Recipient of Welch Foundation Grant F-408.

3 Recipient of USPHS Grant CA 08791-02.

Received 5/10/71. Accepted 7/ 6/71.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1971 by the American Association for Cancer Research.